Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
AUTOR(ES)
Forward, K R
RESUMO
We compared the activity of norfloxacin (MK-0366), a new orally absorbable derivative of naladixic acid, with those of other antipseudomonal agents against Pseudomonas aeruginosa. Norfloxacin was the most active against both gentamicin-susceptible and gentamicin-resistant strains, having 90% minimal inhibitory concentrations of 2 and 8 micrograms/ml, respectively. This excellent in vitro activity may make norfloxacin effective for oral therapy of P. aeruginosa urinary tract infections.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185382Documentos Relacionados
- Comparative Activities of Norfloxacin and Fifteen Other Antipseudomonal Agents Against Gentamicin-Susceptible and -Resistant Pseudomonas aeruginosa Strains
- Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.
- Characterization of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus Involved in Nosocomial Spread
- Reemergence of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus in France: a Phylogenetic Approach
- Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
